Stroke and Assessment of Muscle Tone
Launched by UNIVERSITY OF SEVILLE · Jan 21, 2019
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be older than 18 years
- • Clinical diagnosis of stroke, confirmed using a MRI.
- • No previous history of other strokes.
- • Increases muscle tone in upper and lower extremities (punctuation equal to or superior to 1 in the Tardieu Scale, Ashworth Scale)
- • Ability to understand the study goals, follow simple instructions and provide informed consent.
- • Score equal to or superior to 24 in the Minimental State Examination.
- Exclusion Criteria:
- • Any other confirmed neurological disorder that may influence muscle tone (multiple sclerosis, Parkinson, muscle dystrophies...)
- • A chronic musculoskeletal disorder in the upper or lower limb.
- • Previous history of surgery in the upper or lower extremities.
- • Changes in the medication intake that may affect muscle tone assessments in the 48 hours before data collection.
- • Having received botulin toxin in gastrocnemius or biceps brachii muscles in the 30 days before data collection.
- • A concomitant acute infection during data collection.
- • A previous epileptic crisis in the week before the study or during the study.
About University Of Seville
The University of Seville is a prestigious academic institution dedicated to advancing knowledge through innovative research and exceptional education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at enhancing patient care and medical outcomes. Its commitment to rigorous scientific inquiry and ethical standards positions it as a leading sponsor in the field of clinical research, fostering partnerships with healthcare professionals and institutions to drive advancements in medical science and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sevilla, , Spain
Seville, , Spain
Patients applied
Trial Officials
Isabel Garcia Bernal, PT
Principal Investigator
Physiotherapy Department, University of Sevilla, Spain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials